Funding Rounds
Orasis Pharma Series C round September 2020
Orasis PharmaceuticalsOrasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Summary
Stage: Series C
Raised Amount: $30.00M
Raised Date: 2020-09-01
